Earnings Feed
Start Free
Home/Filings/4/0001654954-19-007193
4//SEC Filing

Hartman William A. 4

Accession 0001654954-19-007193

CIK 0001515740other
View on SEC.govCompany Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:40 PM ET

Size

12.7 KB

Accession

0001654954-19-007193

Insider Transaction Report

Form 4
Period: 2018-12-20
PREMIER BIOMEDICAL INCBIEI
Hartman William A.
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Warrant (right to buy)

    2018-12-20+842,000→ 842,000 total
    Exercise: $0.09From: 2018-12-20Exp: 2025-12-20→ Common Stock (842,000 underlying)
Holdings

  • Warrant (right to buy)

    Exercise: $1.25From: 2017-12-22Exp: 2024-12-22→ Common Stock (34,000 underlying)
    34,000

  • Warrant (right to buy)

    Exercise: $362.50From: 2013-06-15Exp: 2019-09-28→ Common Stock (200 underlying)
    200

  • Warrant (right to buy)

    Exercise: $62.50From: 2015-06-15Exp: 2021-11-18→ Common Stock (6,400 underlying)
    6,400

  • Common Stock

    80,000

  • Warrant (right to buy)

    Exercise: $12.50From: 2015-10-07Exp: 2025-10-07→ Common Stock (4,000 underlying)
    4,000

  • Warrant (right to buy)

    Exercise: $362.50From: 2013-06-15Exp: 2019-09-28→ Common Stock (420 underlying)
    420

  • Series A Convertible Preferred Stock

    Exercise: $0.00From: 2016-01-29→ Common Stock (4,000 underlying)
    4,000
Footnotes (1)
  • [F1]None

Documents

1 file

Issuer

PREMIER BIOMEDICAL INC

CIK 0001515740

→
Entity typeother

Related Parties

1
  • filerCIK 0001472835

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:40 PM ET
Size
12.7 KB
View on SEC.gov